Sonoma Pharmaceuticals News

Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores

BOULDER, CO / ACCESSWIRE / May 9, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn technology based stabilized hypochlorous acid

AccesswireMay 9 07:30 ET

Sonoma Pharmaceuticals Presents Business and Financial Update

TipRanksApr 9 07:42 ET

Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States

BOULDER, CO / ACCESSWIRE / April 9, 2024 / Sonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing patented Microcyn technology based stabilized hypochlorous acid

AccesswireApr 9 07:30 ET

Express News | Sonoma Reports Recent Publication From Australia Highlighting Potential For Microdox In Managing Urinary Tract Infections

Moomoo 24/7Apr 4 07:36 ET

Express News | Sonoma Pharmaceuticals Reported A Recent Publication In The Journal Neurourology And Urodynamics Highlighting The Potential For Microdox In The Management Of Urinary Tract Infections In Children With Neurogenic Or Non‐Neurogenic Bladder Dysfunction

Moomoo 24/7Apr 4 07:36 ET

Sonoma Pharmaceuticals Reports Recent Publication From Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections

BOULDER, CO / ACCESSWIRE / April 4, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn technology based stabilized hypochlorous ac

AccesswireApr 4 07:30 ET

Sonoma Pharmaceuticals Outlines Growth and Challenges

TipRanksApr 2 07:42 ET

Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences

BOULDER, CO / ACCESSWIRE / March 28, 2024 / Sonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing patented Microcyn technology based stabilized hypochlorous acid

AccesswireMar 28 16:01 ET

12 Health Care Stocks Moving In Thursday's Pre-Market Session

GainersAvalo Therapeutics (NASDAQ:AVTX) shares rose 328.2% to $20.34 during Thursday's pre-market session. The company's market cap stands at $16.3 million. Xilio Therapeutics (NASDAQ:XLO) stock moved

BenzingaMar 28 08:06 ET

Sonoma Pharmaceuticals Highlights Safety Advantages of Its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals

BOULDER, CO / ACCESSWIRE / March 27, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn technology based stabilized hypochlorous a

AccesswireMar 27 07:30 ET

Express News | Sonoma Pharmaceuticals Q3 EPS $(0.08) Up From $(0.62) YoY, Sales $3.14M Up From $2.94M YoY

Moomoo 24/7Feb 8 16:44 ET

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results

Revenues increased 7% compared to quarter from prior year and 15% from prior quarterImprovement in gross margin for quarter of 19% compared to prior yearImprovement in net loss for quarter of $1.0 mil

AccesswireFeb 8 16:10 ET

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

GainersKura Oncology (NASDAQ:KURA) stock rose 39.6% to $18.73 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.3 billion. Redhill Biopharma (NASDAQ:RDHL) st

BenzingaJan 24 08:05 ET

Express News | Sonoma Pharmaceuticals Announced The Launch Of Lumacyn Clarifying Mist Direct To Consumers For Over-the-counter Use In The United States

Moomoo 24/7Jan 23 07:35 ET

Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use

BOULDER, CO / ACCESSWIRE / January 23, 2024 / Sonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing patented Microcyn technology based stabilized hypochlorous acid

AccesswireJan 23 07:30 ET

12 Health Care Stocks Moving In Monday's Intraday Session

GainersAtreca (NASDAQ:BCEL) stock rose 52.7% to $0.36 during Monday's regular session. The market value of their outstanding shares is at $14.1 million. Cyclo Therapeutics (NASDAQ:CYTH) shares rose 29

BenzingaJan 15 12:30 ET

NovaBay Pharmaceuticals And Sonoma Pharmaceuticals Agree To Market Avenova-Branded Products In European Union; Sonoma Will Manufacture Ocudox And Pay NovaBay Royalty Fee Based On Net Product Sales

The new products will combine Sonoma's existing eye product Ocudox, which has already received a Class IIB CE mark for sale in the European Union, with Avenova branding, and are expected to be markete

BenzingaJan 9 09:18 ET

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

GainersAllarity Therapeutics (NASDAQ:ALLR) shares rose 44.0% to $0.86 during Tuesday's pre-market session. The company's market cap stands at $3.9 million. Sonoma Pharmaceuticals (NASDAQ:SNOA) stock r

BenzingaDec 5, 2023 08:07 ET

Sonoma Pharmaceuticals GAAP EPS of -$0.29 Misses by $0.05, Revenue of $2.73M Misses by $0.75M

Seeking AlphaNov 14, 2023 01:37 ET

Sonoma Pharmaceuticals Q2 EPS $(0.29) Misses $(0.24) Estimate, Sales $2.73M Miss $3.48M Estimate

Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.24) by 20.83 percent. This is a 12.12 percent increase over losse

BenzingaNov 13, 2023 17:39 ET